-
Moderna will ask the Food and Drug Administration to authorize its vaccine for kids ages 12 to 17 in early June, the company's CEO says.
-
House subcommittee members questioned why Emergent BioSoultions awarded bonuses to executives despite quality problems than hindered production of Johnson & Johnson's COVID-19 vaccine.
-
With the Food and Drug Administration and Centers for Disease Control and Prevention’s latest authorization for the Pfizer COVID-19 vaccine to be used in…
-
Menthol has been the last allowable flavor in cigarettes, and the FDA says marginalized communities are far more likely to use these products.
-
Health and Human Services Secretary Xavier Becerra is reversing restrictions on the use of fetal tissue in medical research implemented under former President Trump.
-
Government health officials are recommending a "pause" in vaccinations with the Johnson & Johnson COVID-19 vaccine. We're answering your questions as we learn more.
-
In a statement on Tuesday, U.S. authorities said they are "reviewing data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the J&J vaccine."
-
More campuses are expected to add the requirement, with potential legal challenges ahead. One key point: Requiring vaccines for infectious diseases is nothing new for many residential colleges.
-
Researchers are reporting some progress in their search for drugs that tamp down the overwhelming immune reaction that can kill a patient with COVID-19.
-
Moderna has begun testing its vaccine on children as young as 6 months old. A principal investigator in the trial says getting children vaccinated would be "a step getting back to our normal life."